| Original language | English (US) |
|---|---|
| Pages (from-to) | 410-412 |
| Number of pages | 3 |
| Journal | Circulation |
| Volume | 139 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jan 15 2019 |
Fingerprint
Keywords
- cholesterol
- clinical trial
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Physiology (medical)
Cite this
}
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. / Virani, Salim S.; Akeroyd, Julia M.; Nambi, Vijay; Michos, Erin D.; Morris, Pamela B.; Nasir, Khurram; Smith, Sidney C.; Stone, Neil J; Petersen, Laura A.; Ballantyne, Christie M.
In: Circulation, Vol. 139, No. 3, 15.01.2019, p. 410-412.Research output: Contribution to journal › Letter
TY - JOUR
T1 - Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial
AU - Virani, Salim S.
AU - Akeroyd, Julia M.
AU - Nambi, Vijay
AU - Michos, Erin D.
AU - Morris, Pamela B.
AU - Nasir, Khurram
AU - Smith, Sidney C.
AU - Stone, Neil J
AU - Petersen, Laura A.
AU - Ballantyne, Christie M.
PY - 2019/1/15
Y1 - 2019/1/15
KW - cholesterol
KW - clinical trial
UR - http://www.scopus.com/inward/record.url?scp=85060035929&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060035929&partnerID=8YFLogxK
U2 - 10.1161/CIRCULATIONAHA.118.034993
DO - 10.1161/CIRCULATIONAHA.118.034993
M3 - Letter
VL - 139
SP - 410
EP - 412
JO - Circulation
JF - Circulation
SN - 0009-7322
IS - 3
ER -